Jan 22 (Reuters) - ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL):
* ISR IMMUNE SYSTEM REGULATION HOLDING AB STARTS TWO NEW PROGRAMS AGAINST TBC AND CANCER
* PLANS TO INITIATE A PHASE I SAFETY STUDY IN HUMANS DURING FALL OF 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 